KLOW is a proprietary research peptide blend composed of four distinct peptides: BPC-157, GHK-Cu, TB-500, and KPV. Each component represents a different structural class and targets complementary biological mechanisms, combined in lyophilized form for use in advanced laboratory studies.
The KLOW blend combines peptides individually studied for tissue healing (BPC-157, TB-500), collagen synthesis and antioxidant protection (GHK-Cu), and anti-inflammatory modulation (KPV — a tripeptide derived from α-MSH). Their combination is explored for multi-peptide signaling interactions in in vitro systems.
KPV (Lys-Pro-Val) is a C-terminal tripeptide of α-MSH, studied for its anti-inflammatory properties via melanocortin MC1R receptors, its ability to inhibit NF-κB, and to reduce pro-inflammatory cytokines (IL-1β, TNF-α) in models of inflammatory bowel disease.
| Components | BPC-157 · GHK-Cu · TB-500 · KPV |
| Form | Lyophilized white to off-white powder |
| Lyophilized storage | −20°C (−4°F) |
| After reconstitution | 2–8°C (36–46°F) · use promptly |
| Purity | ≥99% HPLC (each peptide certified) |


























Reviews
There are no reviews yet.